InsidersTradesSigma
Browse the complete record of transactions filed by Nicaise Claude, Directeur. Insider active across 1 companies, notably Sarepta Therapeutics, Inc.. Cumulatively, 1 reports have been published. The latest transaction was filed on 7 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Nicaise Claude is a Director at Sarepta Therapeutics, Inc. He plays a key role in the governance of the company, participating in strategy development and performance oversight. His expertise helps guide management and ensure compliance with regulations.